Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Chemotherapy for the initial treatment of metastatic prostate adenocarcinoma and neuroendocrine carcinoma at diagnosis: real world application and impact in the SEER database (2004 –2018)

Frontiers in Oncology(2023)10.3389/fonc.2023.1165188Source: DataRank Database

Chemotherapy for the initial treatment of metastatic prostate adenocarcinoma and neuroendocrine carcinoma at diagnosis: real world application and impact in the SEER database (2004 –2018) is a research paper published in Frontiers in Oncology (2023). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 0.00)OA: goldTopics (22)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Ming Yin ORCID,Peng Wang ORCID,Edmund Folefac ORCID,J. Paul Monk,Fred K. Tabung ORCID

Live enrichment

PubMed:37361592 PMC:PMC10288985 OpenAlex:https://openalex.org/W4380079718

NCI NIH HHS

Grant: P30 CA016058

National Institutes of Health

Grant: 3P30CA016058-15S1

CORE--HORMONE RECEPTOR LABORATORY

FWCI

0.00

Citation Percentile

0.1%

goldLicense: cc-by

journalhttps://doi.org/10.3389/fonc.2023.1165188

publisherhttps://doi.org/10.3389/fonc.2023.1165188

publisherhttps://www.frontiersin.org/articles/10.3389/fonc.2023.1165188/full

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37361592

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/10288985

Fields of Study

Prostate Cancer Treatment and ResearchProstate Cancer Diagnosis and TreatmentRadiopharmaceutical Chemistry and Applications03 medical and health sciences0302 clinical medicine

Keywords

MedicineHazard ratioOncologyInternal medicineChemotherapyProstate cancerAdenocarcinomaCancerProportional hazards modelSurveillance, Epidemiology, and End ResultsConfidence intervalCancer registryNeuroendocrineSeerCancer ResearchNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282

Sustainable Development Goals

SDG 0: No poverty